FacebookTwitterGoogle+RedditEmail

The Pharmaceuticalization of Marijuana

G.W. Does the “Right” Thing

A hitherto reliable source says that G.W. Pharmaceuticals has hired Andrea Barthwell, MD, to lobby for approval of its cannabis-plant extracts in the U.S. G.W. manufactures a high-THC spray called Sativex that is awaiting marketing approval in Britain and Canada. They also make a high-CBD formulation, and a 50-50 mix. Barthwell, a specialist in addiction medicine, is a liberal Republican from Illinois. She was employed for two years in the Office of National Drug Control Policy under Bush’s “drug czar,” John Walters, and she left with an eye towards running for the Senate (for the seat that was won by Barak Obama).

G.W. has also hired John Pastuovic, who headed the Bush-Cheney campaign in Illinois in 2000, to handle public relations in the U.S. The implication of the hires is that G.W. founders Geoffrey Guy and Brian Whittle will use any means necessary to push their products as alternatives to smoked marijuana. Our source says, “As a stockholder -bravo! As a citizen -what a shame!” Lester Grinspoon, MD, foresaw this development several years ago and defined G.W.’s approach as “the pharmaceuticalization of marijuana.” After O’Shaughnessy’s published an article by Grinspoon, Guy expressed slightly hurt feelings, which I tried to assuage with a song. Approval by Britain or Canada will assuage them a lot better, no doubt.

Sativa is a pretty plant
It grows tall and green
With 68 cannabinoids
And the spicy-sweet terpenes
Guy says I can market this
I’ll put it in a spray
Grinspoon says let’s grow our own
Why should people have to pay?

Guy says some prefer it neat
And some don’t like the high
Grinspoon says the government
Won’t even let ’em try
Euphoria’s a side effect
Could do a lot of good
Guys says I’m all for ya, please
Don’t let me be misunderstood

We’re dealing with a system that
Is not about to change
Grinspoon says why not
Reinvent the grange?
And let a thousand farmers grow
Every helpful strain…
Guy says my approval wasn’t easy
Or cheap to almost obtain

Sativex is a useful drug
It bears the Bayer brand
Grinspoon shrugs his shoulders
Takes the bottle in his hand
“You’re right from your side
And I am right from mine
We’re just one too many mornings
And a thousand miles behind…”

 

Dueling Anti-inflammatories

This month the FDA ordered Pfizer to stop selling Bextra, a Cox-2 anti-inflammatory drug known to cause heart attacks and strokes, but made two moves in the drug company’s interests. Pfizer is allowed to keep marketing its top-selling Cox-2 inhibitor, Celebrex, with a “black box” warning. And, at the same time, the makers of other non-steroidal anti-inflammatories have been ordered to carry black-box warnings. So, millions of arthritis sufferers and other chronic pain patients are likely to conclude that Celebrex is as safe as the others -which it isn’t- and keep taking it.

Meanwhile, the April 7 issue of Nature published a study entitled “Low dose oral cannabinoid therapy reduces progression of atherosclerosis in mice” by a group of Swiss and German investigators led by Francois Mach. They fed THC in doses of one milligram per kilogram of body weight to mice with clogged arteries and found that cells involved in plaque formation “showed diminished proliferation capacity.” The effects were blocked by a CB2 receptor antagonist. Mach et al concluded, “THC or cannabinoids with activity at the CB2 receptor may be valuable targets for treating atherosclerosis.”

But don’t let ’em have any marijuana in the meantime.
Prop 215 Demographics

As the Drug Warriors strive to curtail implementation of California’s medical marijuana law, they increasingly invoke “the will of the voters.” It is now being alleged by politicians, editorial writers and law enforcement agents (whose unions strongly opposed Prop 215) that we, the voters didn’t really intend to authorize use of marijuana as a treatment for any condition for which it provides relief. Nor did we mean to confer immunity on doctors by the words “no physician in this state shall be punished, or denied any right or privilege, for having recommended marijuana to a patient for medical purposes.”

Although the meaning of the vote might be obscured, the margin of victory -56 to 44 per cent- is a historic fact. A more detailed breakdown was provided by the Los Angeles Times, which queried 2,473 Californians as they exited 40 polling places across the state on November 5, 1996. For the record:

% of All Voters Yes No
47% Male 53% 47%
53% Female 58% 42%

AGE
19% 18-29 62% 38%
35% 30-44 60% 40%
35% 45-64 53% 47%
11% 65 and Older 40% 60%

RACE/ETHNICITY
74% White 56% 44%
7% Black 70% 30%
10% Latino 49% 51%
5% Asian 49% 51%

EDUCATION
20% High School or Less 49% 51%
29% Some College 58% 42%
27% College or More 56% 44%
24% Postgraduate 58% 42%

INCOME
12% Less Than $20,000 62% 38%
24% $20,000 to $39,999 56% 44%
23% $40,000 to $59,999 51% 49%
15% $60,000 to $74,999 54% 46%
26% $75,000 or more 59% 41%

POLITICAL IDE0LOGY
21% Liberal 78% 22%
47% Moderate 63% 37%
32% Conservative 29% 71%

POLITICAL AFFILIATION
45% Democrats 70% 30%
14% Independents 65% 35%
38% Republicans 34% 66%

RELIGION
49% Protestant 44% 56%
24% Catholic 54% 46%
6% Jewish 75% 25%

FRED GARDNER can be reached at journal@ccrmg.org

 

 

 

 

 

 

 

 

 

More articles by:

Fred Gardner is the managing editor of O’Shaughnessy’s. He can be reached at fred@plebesite.com

August 20, 2018
Carl Boggs
The Road to Disaster?
James Munson
“Not With a Bomb, But a Whimper” … Then More Bombs.
Jonathan Cook
Corbyn’s Labour Party is Being Made to Fail –By Design
Robert Fisk
A US Trade War With Turkey Over a Pastor? Don’t Believe It
Howard Lisnoff
The Mass Media’s Outrage at Trump: Why the Surprise?
Faisal Khan
A British Muslim’s Perspective on the Burkha Debate
Andrew Kahn
Inhumanity Above the Clouds
Dan Glazebrook
Trump’s New Financial War on the Global South
George Wuerthner
Why the Gallatin Range Deserves Protection
Ted Rall
Is Trump a Brand-New Weird Existential Threat? No.
Sheldon Richman
For the Love of Reason
Susie Day
Why Pundits Scare Me
Dean Baker
Does France’s Economy Need to Be Renewed?
Weekend Edition
August 17, 2018
Friday - Sunday
Daniel Wolff
The Aretha Dialogue
Nick Pemberton
Donald Trump and the Rise of Patriotism 
Joseph Natoli
First Amendment Rights and the Court of Popular Opinion
Andrew Levine
Midterms 2018: What’s There to Hope For?
Robert Hunziker
Hothouse Earth
Jeffrey St. Clair
Roaming Charges: Running Out of Fools
Ajamu Baraka
Opposing Bipartisan Warmongering is Defending Human Rights of the Poor and Working Class
Paul Street
Corporate Media: the Enemy of the People
David Macaray
Trump and the Sex Tape
CJ Hopkins
Where Have All the Nazis Gone?
Daniel Falcone
The Future of NATO: an Interview With Richard Falk
Cesar Chelala
The Historic Responsibility of the Catholic Church
Ron Jacobs
The Barbarism of US Immigration Policy
Kenneth Surin
In Shanghai
William Camacaro - Frederick B. Mills
The Military Option Against Venezuela in the “Year of the Americas”
Nancy Kurshan
The Whole World Was Watching: Chicago ’68, Revisited
Robert Fantina
Yemeni and Palestinian Children
Alexandra Isfahani-Hammond
Orcas and Other-Than-Human Grief
Shoshana Fine – Thomas Lindemann
Migrants Deaths: European Democracies and the Right to Not Protect?
Paul Edwards
Totally Irrusianal
Thomas Knapp
Murphy’s Law: Big Tech Must Serve as Censorship Subcontractors
Mark Ashwill
More Demons Unleashed After Fulbright University Vietnam Official Drops Rhetorical Bombshells
Ralph Nader
Going Fundamental Eludes Congressional Progressives
Hans-Armin Ohlmann
My Longest Day: How World War II Ended for My Family
Matthew Funke
The Nordic Countries Aren’t Socialist
Daniel Warner
Tiger Woods, Donald Trump and Crime and Punishment
Dave Lindorff
Mainstream Media Hypocrisy on Display
Jeff Cohen
Democrats Gather in Chicago: Elite Party or Party of the People?
Victor Grossman
Stand Up With New Hope in Germany?
Christopher Brauchli
A Family Affair
Jill Richardson
Profiting From Poison
Patrick Bobilin
Moving the Margins
FacebookTwitterGoogle+RedditEmail